December 31, 2014 — Innovative Cardiovascular Solutions LLC has completed a Class A Unit financing totaling $5 million to fund its Emblok Embolic Protection Catheter. It is designed to be utilized in transaortic valve replacement (TAVR) procedures as well as several other left heart interventional procedures where embolic protection would be required.
The Emblok device offers full circumferential aortic collection while protecting the cerebral, abdominal and peripheral vasculature from embolic debris. The design of the Emblok system allows the physician constant visualization during the procedure and aids in precise valve implantation while eliminating the need for constant dye injections to verify positioning.